Now showing items 1-1 of 1

    • Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa 

      Anzala, Aggrey O.; Jaoko Walter G.; Karita, E.; Kayitenkore, K.; Than, S.; Adams, EM.; Graham, BS.; Koup, RA.; Bailer, RT.; Smith, C.; Dally, L.; Farah, B.; Muvunyi, CM.; Bizimana, J.; Tarragona-Fiol, T.; Bergin, PJ.; Hayes, P.; Ho, M.; Loughran, K.; Komaroff, W.; Stevens, G.; Thomson, H.; Boaz, MJ.; Cox, JH.; Schmidt, C.; Gilmour, J.; Nabel, GJ.; Fast, P. (University of nairobiCollege of health science, 2010)
      Abstract BACKGROUND: We conducted a double-blind, randomized, placebo-controlled Phase I study of a recombinant replication-defective adenovirus type 5 (rAd5) vector expressing HIV-1 Gag and Pol from subtype B and Env ...